Lifevantage Q3 2024 Adj EPS $0.21 Beats $0.16 Estimate, Sales $48.245M Miss $52.182M Estimate
Portfolio Pulse from Benzinga Newsdesk
Lifevantage (NASDAQ:LFVN) reported Q3 2024 adjusted EPS of $0.21, surpassing the $0.16 estimate, marking a 162.5% increase from last year. However, sales of $48.245M fell short of the $52.182M estimate, a 10.23% decrease from the previous year.
May 02, 2024 | 9:04 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Lifevantage reported a strong Q3 2024 EPS of $0.21, beating estimates, but sales missed expectations at $48.245M, indicating mixed financial health.
The positive earnings beat suggests operational efficiency and profitability, which could support the stock price. However, the sales miss, especially a 10.23% decrease YoY, could raise concerns about growth and demand, potentially offsetting the positive EPS impact. The mixed results make the short-term stock price direction uncertain, hence a neutral score.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100